Details for New Drug Application (NDA): 209182
✉ Email this page to a colleague
The generic ingredient in NEOSTIGMINE METHYLSULFATE is neostigmine methylsulfate. There are nine drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the neostigmine methylsulfate profile page.
Summary for 209182
Tradename: | NEOSTIGMINE METHYLSULFATE |
Applicant: | Am Regent |
Ingredient: | neostigmine methylsulfate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 209182
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;INTRAVENOUS | Strength | 5MG/10ML (0.5MG/ML) | ||||
Approval Date: | May 4, 2018 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;INTRAVENOUS | Strength | 10MG/10ML (1MG/ML) | ||||
Approval Date: | May 4, 2018 | TE: | RLD: | No |
Complete Access Available with Subscription